Prostate Cancer
Prostate Cancer falls under theCancercategory.
Last Updated:October 13, 2024
Prostate cancer is a disease characterized by uncontrolled growth of cells in the prostate gland, which is part of the male reproductive system. It is the second most common cancer in men and particularly affects people older than age 65. Although most cases progress slowly and have a good prognosis when confined to the prostate, aggressive forms that spread can be dangerous and incurable.
The main signs and symptoms of prostate cancer are nonspecific and often resemble those of benign prostatic hyperplasia; they primarily involve urinary issues such as decreased urinary stream, frequent urination, and pain while urinating. In rare cases, symptoms of metastatic disease, like bone pain or fractures, may also occur.
Prostate cancer is diagnosed through various tests, including a digital rectal exam, a prostate-specific antigen (PSA) blood test, and imaging tests like ultrasound or MRI. A prostate biopsy is then performed to confirm the diagnosis and assess the severity of the cancer.
Medical treatments for prostate cancer vary based on factors such as age, health status, cancer stage, and individual preferences, and common options include watchful waiting, surgery, radiation therapy, hormone therapy, chemotherapy, targeted therapy, and immunotherapy. Watchful waiting is often recommended for older individuals with less aggressive cancer, whereas surgery and radiation are typically used in the early stages to attempt a cure.
Several supplements with antioxidant effects — such as curcumin, soy isoflavones, green tea catechins, pomegranate, lycopene, vitamin E, vitamin D, selenium, and zinc — have been studied for their potential role in reducing the risk of or treating prostate cancer due to the association between oxidative stress and the disease.
A Western diet that is high in animal-based proteins and dairy products is associated with an increased risk of prostate cancer, whereas a plant-based diet, such as the Mediterranean diet, is associated with a decreased risk. Additionally, a high dairy intake raises risk, whereas lycopene from tomatoes may lower it, and obesity can increase the risk of advanced prostate cancer, which makes weight loss beneficial.
Increased physical activity is associated with a reduced risk of prostate cancer and its mortality, whereas cigarette smoking is associated with a higher risk of progression and mortality from the disease.
The causes of prostate cancer are not fully understood, but they involve DNA changes in prostate cells that can be inherited or acquired; several genes are associated with the disease, and acquired mutations may result from random DNA errors or external factors like diet and chemical exposure. Additionally, Black men or men who have a first-degree relative with prostate cancer have a higher risk.
Unlock the full potential of Examine
- ^The content of this page was partially adapted from MedlinePlus of the National Library of Medicine
- ^Mattiuzzi C, Lippi GCurrent Cancer Epidemiology.J Epidemiol Glob Health.(2019-12)
- ^American Cancer SocietyTreating Prostate Cancer
- ^Leslie SW, Soon-Sutton TL, Sajjad H, Siref LEProstate CancerStatPearls.(2022-07)
- ^PDQ Integrative, Alternative, and Complementary Therapies Editorial BoardProstate Cancer, Nutrition, and Dietary Supplements (PDQ®): Health Professional Version
- ^Maria G Grammatikopoulou, Konstantinos Gkiouras, Stefanos Τ Papageorgiou, Ioannis Myrogiannis, Ioannis Mykoniatis, Theodora Papamitsou, Dimitrios P Bogdanos, Dimitrios G GoulisDietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled TrialsNutrients.(2020 Sep 29)
- ^Wilson KM, Mucci LADiet and Lifestyle in Prostate Cancer.Adv Exp Med Biol.(2019)
- ^Lin PH, Aronson W, Freedland SJAn update of research evidence on nutrition and prostate cancer.Urol Oncol.(2019-06)
- ^Rowles JL, Ranard KM, Applegate CC, Jeon S, An R, Erdman JWProcessed and raw tomato consumption and risk of prostate cancer: a systematic review and dose-response meta-analysis.Prostate Cancer Prostatic Dis.(2018-09)
- ^Rowles JL, Ranard KM, Smith JW, An R, Erdman JWIncreased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis.Prostate Cancer Prostatic Dis.(2017-12)
- ^Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SAProstate cancer progression and mortality: a review of diet and lifestyle factors.World J Urol.(2017-Jun)
- ^Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SGProstate cancer.Lancet.(2021-09-18)
- ^American Cancer SocietyWhat Causes Prostate Cancer?
- ^Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine EProstate-specific antigen as a serum marker for adenocarcinoma of the prostate.N Engl J Med.(1987-Oct-08)
- ^David MK, Leslie SWProstate Specific AntigenStatPearls.(2022-04)
- ^Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CAOperating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.JAMA.(2005-Jul-06)
- ^Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, Agoritsas T, Dahm PProstate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.BMJ.(2018-Sep-05)
- ^Kilpeläinen TP, Tammela TL, Roobol M, Hugosson J, Ciatto S, Nelen V, Moss S, Määttänen L, Auvinen AFalse-positive screening results in the European randomized study of screening for prostate cancer.Eur J Cancer.(2011-Dec)
- ^, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CWScreening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.JAMA.(2018-05-08)
- ^American Cancer Society(2022-01-18)
- ^American Cancer SocietyRadiation Therapy For Prostate Cancer(2022-03-24)
- ^National Cancer InstituteSide Effects of Cancer Treatment
- ^American Cancer SocietyHormone Therapy for Prostate Cancer(2021-09-23)
- ^American Cancer SocietyChemotherapy for Prostate Cancer(2019-08-01)
- ^PDQ Adult Treatment Editorial BoardProstate Cancer Treatment (PDQ®): Patient Version
- ^American Cancer SocietyImmunotherapy for Prostate Cancer(2019-08-01)
- ^Ørsted DD, Bojesen SEThe link between benign prostatic hyperplasia and prostate cancer.Nat Rev Urol.(2013-Jan)
- ^Miah S, Catto JBPH and prostate cancer risk.Indian J Urol.(2014-Apr)
- ^Dai X, Fang X, Ma Y, Xianyu JBenign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.Medicine (Baltimore).(2016-May)
- ^Zhang L, Wang Y, Qin Z, Gao X, Xing Q, Li R, Wang W, Song N, Zhang WCorrelation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.J Cancer.(2020)
- ^Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GPThe association of benign prostatic hyperplasia and cancer of the prostate.Cancer.(1992-Jul-01)
- Prostate Cancer Risk - C J Paller, X Ye, P J Wozniak, B K Gillespie, P R Sieber, R H Greengold, B R Stockton, B L Hertzman, M D Efros, R P Roper, H R Liker, M A CarducciA randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancerProstate Cancer Prostatic Dis.(2013 Mar)
- Prostate Cancer Risk - Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun APhase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancerClin Cancer Res.(2006 Jul 1)
- Prostate Cancer Risk - Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, Mäenpää H, Teerenhovi L, Koss L, Virolainen M, Edwards BKProstate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trialJ Natl Cancer Inst.(1998 Mar 18)
- Prostate Cancer Risk - Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA JrEffect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)JAMA.(2009 Jan 7)
- Prostate Cancer Risk - Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LHVitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)JAMA.(2011 Oct 12)
- Prostate Cancer Risk - Choi YH, Han DH, Kim SW, Kim MJ, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HYA randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivationProstate.(2019 May)
- Prostate Cancer Risk - Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, Beynon R, Savovic J, Fairweather-Tait SJSelenium and prostate cancer: systematic review and meta-analysisAm J Clin Nutr.(2012 May 30)
- Prostate Specific Antigen - Ya-Feng Yang, Preety Babychen Mattamel, Tanya Joseph, Jian Huang, Qian Chen, Babatunde O Akinwunmi, Casper J P Zhang, Wai-Kit MingEfficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNutrients.(2021 Apr 21)
- High-density lipoprotein (HDL) - Amanollahi A, Khazdouz M, Malekahmadi M, Klement RJ, Lee D, Khodabakhshi AEffect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials.Nutr Cancer.(2023)
- Weight - Marzieh Taftian, Sara Beigrezaei, Vahid Arabi, Amin Salehi-AbargoueiThe Effect of Ketogenic Diet on Weight Loss in Adult Patients with Cancer: A Systematic Review and Meta-Analysis of Controlled Clinical TrialsNutr Cancer.(2022 Feb 7)
- Prostate Specific Antigen - lker Durak, PhD, Erdal Yılmaz, MD, Erdinç Devrim, MD, Hakkı Perk, MD, Murat Kaçmaz, MDConsumption of aqueous garlic extract leads to significant improvement in patients with benign prostate hyperplasia and prostate cancerNutrition Research.()
- Muscle Mass - Fairman CM, Kendall KL, Newton RU, Hart NH, Taaffe DR, Lopez P, Chee R, Tang CI, Galvão DACreatine supplementation does not add to resistance training effects in prostate cancer patients under androgen deprivation therapy: A double-blind randomized trial.J Sci Med Sport.(2024 Sep 14)